Efficacy and Safety of Hydrocodone Bitartrate in Patients With Osteoarthritis or Low Back Pain

Study Title

Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period of Time

Teva Identifier

C33237/3079

ClinicalTrials.gov Identifier

NCT01240863

Study Status

Completed

Trial Condition(s)

Chronic Pain

Interventions

Drug: Hydrocodone ER | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations
pain icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 80 Years

Trial Duration

11/01/2010 - 08/01/2011

Phase

Phase 3

Study Type

Interventional